Home / Diabetes In Control (page 311)

Diabetes In Control

FDA Puts Empagliflozin on Hold

Quality issues in the manufacturing plant prevents final approval…. The investigational type 2 diabetes drug empagliflozin won’t win the FDA’s approval until “previously observed deficiencies” at a manufacturing plant are fixed, the drug’s sponsors said last week. Eli Lilly and Boehringer Ingelheim said the FDA had issued a complete response …

Read More »

Letter from the Editor #719

We often talk about the increase in AGEs (Advanced Glycation Endproducts) in patients with diabetes. We mainly think about these AGE’s in the development of vascular injury in our diabetes patients. However, the collagen in our joints is also subject to glycosylation and this means that many of our diabetes …

Read More »

Obesity 2014, Part 5

DCMS178HS

  In this week’s Homerun Slides, we continue our exploration of the current obesity crisis with a discussion of prediabetes, the conditions which can lead to prediabetes including genetic disposition, and the possibility of preventing the onset of diabetes by acting quickly…. 

Read More »